MARCHINI, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 10.674
EU - Europa 6.559
AS - Asia 3.621
SA - Sud America 437
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 6
AN - Antartide 1
Totale 21.377
Nazione #
US - Stati Uniti d'America 10.285
CN - Cina 1.665
RU - Federazione Russa 1.349
IT - Italia 1.341
PL - Polonia 1.297
SG - Singapore 994
DE - Germania 777
GB - Regno Unito 395
BR - Brasile 367
CA - Canada 336
UA - Ucraina 335
SE - Svezia 307
HK - Hong Kong 293
FR - Francia 235
FI - Finlandia 216
TR - Turchia 139
VN - Vietnam 134
KR - Corea 133
IE - Irlanda 79
IN - India 74
MX - Messico 41
AT - Austria 35
BE - Belgio 35
AR - Argentina 33
NL - Olanda 33
ES - Italia 27
CZ - Repubblica Ceca 26
EU - Europa 26
JP - Giappone 25
BD - Bangladesh 23
IR - Iran 22
ZA - Sudafrica 22
PK - Pakistan 20
RO - Romania 16
BH - Bahrain 14
LT - Lituania 13
AE - Emirati Arabi Uniti 10
EG - Egitto 10
EC - Ecuador 8
VE - Venezuela 8
ID - Indonesia 7
IL - Israele 7
KZ - Kazakistan 7
PT - Portogallo 7
AZ - Azerbaigian 6
IQ - Iraq 6
KG - Kirghizistan 5
PY - Paraguay 5
BG - Bulgaria 4
CL - Cile 4
CO - Colombia 4
HN - Honduras 4
LV - Lettonia 4
MA - Marocco 4
PE - Perù 4
PH - Filippine 4
RS - Serbia 4
TW - Taiwan 4
UZ - Uzbekistan 4
AL - Albania 3
BY - Bielorussia 3
CH - Svizzera 3
EE - Estonia 3
JO - Giordania 3
KE - Kenya 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PA - Panama 3
SA - Arabia Saudita 3
AU - Australia 2
CY - Cipro 2
DK - Danimarca 2
DZ - Algeria 2
GE - Georgia 2
GY - Guiana 2
HU - Ungheria 2
MD - Moldavia 2
ML - Mali 2
QA - Qatar 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
UG - Uganda 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GR - Grecia 1
JM - Giamaica 1
KI - Kiribati 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MG - Madagascar 1
Totale 21.369
Città #
Warsaw 1.143
Fairfield 992
Woodbridge 961
Ashburn 835
Jacksonville 811
Houston 660
Chandler 601
Ann Arbor 508
Wilmington 473
Seattle 463
Singapore 398
Cambridge 356
Boardman 332
Camerino 298
Hong Kong 292
Nanjing 277
Beijing 232
Toronto 203
The Dalles 176
Los Angeles 164
Dallas 149
New York 147
Kraków 146
Dearborn 130
Seoul 128
San Mateo 126
Tongling 122
Princeton 107
Lawrence 106
Columbus 99
Istanbul 99
Nanchang 98
Helsinki 97
Ogden 92
London 88
Düsseldorf 83
Dublin 79
Moscow 76
Lachine 72
Buffalo 69
Kunming 62
Milan 61
Shenyang 57
Shanghai 56
Dong Ket 50
San Diego 48
Centro 47
Hebei 45
São Paulo 45
Guangzhou 44
Munich 44
Tianjin 44
Chicago 43
Jinan 42
Jiaxing 41
Council Bluffs 35
Hefei 34
Brussels 33
Rome 33
Verona 32
Falls Church 31
Ho Chi Minh City 31
Changsha 30
Montreal 30
Zhengzhou 29
Venezia 28
Vienna 27
Hangzhou 26
Redwood City 26
Valle 25
Brooklyn 24
Ningbo 23
Phoenix 23
Denver 22
Tokyo 22
Santa Clara 21
Hanoi 20
Athens 19
Bologna 19
Brno 19
Philadelphia 19
Wuhan 19
Redondo Beach 18
Napoli 17
San Francisco 17
Chennai 16
Jinhua 16
Johannesburg 16
Nürnberg 16
Ardabil 15
Atlanta 15
Avellino 15
Orem 15
Ancona 14
Ankara 14
Boston 14
Venice 14
Kocaeli 13
Manchester 13
Poplar 13
Totale 13.988
Nome #
Antioxidant and antiproliferative activities of different varieties of cauliflower (Brassica oleracea var. botrytis) after cooking processes. 442
Complessi di rutenio con attività chemioterapica antitumorale 397
In vivo protein corona patterns of lipid nanoparticles 369
The intracellular trafficking mechanism of Lipofectamine-based transfection reagents and its implication for gene delivery 342
Personalized liposome–protein corona in the blood of breast, gastric and pancreatic cancer patients 323
VirF Relieves the Transcriptional Attenuation of the Virulence Gene icsA of Shigella flexneri Affecting the icsA mRNA-RnaG Complex Formation 319
Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition 309
Resveratrol fuels HER2 and ERα‐positive breast cancer behaving as proteasome inhibitor 308
Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor 307
The water soluble ruthenium(II) organometallic compound[Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Clsuppresses triple negative breast cancer growth by inhibiting tumorinfiltration of regulatory T cells 306
Aspirin modulates LPS-induced nitric oxide release in rat glial cells 296
Manipulation of lipoplex concentration at the cell surface boosts transfection efficiency in hard-to-transfect cells 259
Phage-based anti-HER2 vaccination can circumvent immune tolerance against breast cancer 253
Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice 253
A novel 39-tRNAGlu-derived fragment acts as a tumor-suppressor in breast cancer by targeting nucleolin 247
Identification of Relevant Conformational Epitopes on the HER2 Oncoprotein by Using Large Fragment Phage Display (LFPD) 243
Tailoring DNA vaccines: designing strategies against HER2-positive cancers 243
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins. 241
Cholesterol dependent macropinocytosis and endosomal escape control the transfection efficiency of lipoplexes in CHO Living Cells 238
Tumor vessel compression hinders perfusion of ultrasonographic contrast agents 236
HER2-Driven carcinogenesis: new mouse models for novel immunotherapies 235
Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signaling 232
Walking a Tightrope: A Perspective of Resveratrol Effects on Breast Cancer. 230
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2- positive breast carcinomas resistant to Lapatinib 226
Azolate/phosphane Gold(I) compounds in antiproliferative therapy: a new frontier for the azolate gold(I) chemistry 225
In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancer 225
Combination of Coenzyme Q10 intake and moderate physical activity counteracts mitochondrial dysfunctions in a SAMP8 mouse model Oxidative Medicine and Cellular Longevity. 224
The Human Splice Variant Δ16HER2 Induces Rapid Tumor Onset in a Reporter Transgenic Mouse. 223
Factors Determining the Superior Performance of Lipid/DNA/Protammine Nanoparticles over Lipoplexes. 219
Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells 216
NANOPARTICELLE LIPIDICHE MULTICOMPONENTI E PROCEDIMENTI PER LA LORO PREPARAZIONE 216
Cyclooxygenase-2 (COX2) gene silencing with siRNA could enhance DNA vaccination to inhibit established ErbB-2 carcinomas 215
Structure-function relationships in bovine thymus 20S proteasome: a fluorimetric study 214
Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain. 213
Getting the most from gene delivery by repeated DNA transfections 212
Azolate gold(I) phosphane complexes as innovative therapies for the treatment of HER2-driven breast cancer 209
p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells 207
IN VITRO AND IN VIVO STUDIES FOR THE TREATMENT OF BASAL LIKE BREAST CANCER (BLBC) WITH AZOLATE/PHOSPHANE GOLD(I) COMPOUNDS 203
Vaccination trials against bovine herpesvirus-1 200
Chimeric rat/human HER2 efficiently circumvents HER2 tolerance in cancer patients 199
Toward the Rational Design of Lipid Gene Vectors: Shape Coupling between Lipoplex and Anionic Cellular Lipids Controls the Phase Evolution of Lipoplexes and the Efficiency of DNA Release 198
Tailoring lipoplex composition to the lipid composition of plasma membrane: a Trojan horse for cell entry? 198
Role of temperature-independent lipoplex-cell membrane interactions in the efficiency boost of multicomponent lipoplexes. 198
Ruthenium Complexes with Antitumoral Chemiotherapy Activites 196
Characterization of an inwardly rectifying chloride conductance expressed by cultured rat cortical astrocytes. 193
Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof 187
CCL16 enhances the CD8+ and CD4+ T cell reactivity to human HER-2 elicited by dendritic cells loaded with rat ortholog HER-2 186
Transfection efficiency boost by designer multicomponent lipoplexes 186
Mechanistic evaluation of the transfection barriers involved in lipid-mediated gene delivery: interplay between nanostructure and composition 184
Antiproliferative Activity of a New (Arene)Ruthenium(II) Complex on a Model of Breast Cancer 182
Novel Mechanisms of Cell Uptake in Lipid-Mediated Gene Delivery 180
Lyotropic Liquid-Crystalline Nanosystems as Drug Delivery Agents for 5-Fluorouracil: Structure and Cytotoxicity 180
Protective mechanisms of adenosine in neurons and glial cells. 179
Enhanced transfection efficiency of multicomponent lipoplexes in the regime of optimal membrane charge density 179
Transfection efficiency boost of cholesterol-containing lipoplexes 179
Homeostatic effects of adenosine on potentially neurotoxic glial cell activation. 177
On the correlation between phase evolution of lipoplexes/anionic lipid mixtures and DNA release 177
Multi-Targeted Anticancer Activity of Imidazolate Phosphane Gold(I) Compounds by Inhibition of DHFR and TrxR in Breast Cancer Cells 176
Costrutto di acido nucleico, vettore e vaccino a DNA includenti detto costrutto 172
Pathological immuno-reactions of glial cells in Alzheimer’s disease and possible sites of interference. 171
Two distinct inwardly rectifying conductances are expressed in long term dibutyryl-cyclic-AMP treated rat cultured cortical astrocytes. 170
Efficient escape from endosomes determines the superior efficiency of multicomponent lipoplexes 170
Surface adsorption of protein corona controls the cell uptake mechanism in efficient cationic liposome/DNA complexes in serum. 169
DNA release from cationic liposome/DNA complexes by anionic lipids 169
Indoleamine 2,3-Dioxygenase (IDO) silencing for improved antitumour vaccination 169
LIBRERIA FAGICA DI FRAMMENTI DELLA PROTEINA HER2 168
Breast Cancer Treatment: The Case of Gold(I)-Based Compounds as a Promising Class of Bioactive Molecules 166
p185neu encoding DNA and therapeuticaluses thereof 165
P185neu-encoding DNA and therapeutical uses thereof 165
Surface area of lipid membranes regulates the DNA-binding capacity of cationic liposomes. 163
Cationic lipid/DNA complexes manufactured by microfluidics and bulk self-assembly exhibit different transfection behavior 160
Effect of pH on the structure of lipoplexes 158
Mechanistic Understanding of Gene Delivery Mediated by Highly Efficient Multicomponent Envelope-Type Nanoparticle Systems 158
The Second Ascoli Piceno Conference on Gene Vacciantion in Cancer, October 9-11 2013 157
Restricted innervation of uterus and placenta during pregnancy: evidence for a role of the repelling signal Semaphorin 3A 156
Structural stability and increase in size rationalize the efficiency of lipoplexes in serum. 156
Characterization of two voltage-dependent, inwardly rectifying currents in dibutyryl-cyclic AMP treated cortical astrocytes 155
Programmed packaging of multicomponent envelope-type nanoparticle system for gene delivery. 153
Glia-related pathomechanisms in Alzheimer' s disease: a therapeutic target? 151
Programmed packaging of multicomponent envelope-type nanoparticle system (MENS). 151
Recovery of deficient cholinergic calcium signaling by adenosine in cultured rat cortical astrocytes 149
Pathological immuno-reactions of glial cells in Alzheimer’s disease and possible sites of interference. 145
Stathmin is required for normal mouse mammary gland development and Δ16HER2-driven tumorigenesis 145
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer 142
Cascading glial reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling. 142
Self-assembled ternary complexes of neutral liposomes, DNA and bivalent metal cations. Promising vectors for gene transfer? 141
p185neu-Encoding DNA and therapeutical uses thereof 140
DNA codificante forme tronche e chimeriche della proteina p185neu e suoi usi terapeutici 139
Second Ascoli Piceno conference on gene vaccination in cancer (GVC), Ascoli Piceno, Italy, October 9–11, 2013 139
DNA codificante p185neu e suoi usi terapeutici 139
Effects of a supplementation with tart cherry (Prunus cerasus L.) juice and its kernel extract on antioxidant status and muscle health 134
Structural stability against disintegration by anionic lipids rationalizes the efficency of cationic liposom/DNA complexes 131
Mesenchymal/stromal gene expression signature relates to Basal-like breast cancers, identify bone metastasis and predicts resistance to therapies. 131
Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof 128
Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favors early tumor growth in syngeneic mice. 125
Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof 123
Different expression of membrane conductances in cultured rat cortical astrocytes induced by intracellular cyclic-AMP elevation 115
Support of homeostatic glial cell signaling: a novel therapeutic approach by propentofylline. In: Cerebrovascular Pathology in Alzheimer’s disease. 113
Coinage Metal Compounds With 4-Methoxy-Diphenylphosphane Benzoate Ligand Inhibit Female Cancer Cell Growth 111
DNA immunization against Bovine Herpesvirus-1 infection. Preliminary tests in calves with a DNA vaccine 111
Totale 19.824
Categoria #
all - tutte 84.360
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.360


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.603 0 0 0 0 0 190 311 81 222 116 424 259
2021/20221.362 90 314 37 60 95 84 52 96 128 117 154 135
2022/20231.653 172 43 88 214 171 239 10 140 300 103 124 49
2023/20241.224 158 75 82 42 55 138 46 40 139 41 26 382
2024/20253.941 145 69 292 153 133 184 520 1.019 318 300 225 583
2025/20262.681 407 339 432 810 616 77 0 0 0 0 0 0
Totale 21.698